Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) Price Target at $53.29

Astrana Health, Inc. (NASDAQ:ASTH) has been given an average rating of “Moderate Buy” by the ten ratings firms that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $53.29.

Several research firms recently issued reports on ASTH. Bank of America cut their price objective on Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Truist Financial cut their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday, March 18th. Barclays started coverage on Astrana Health in a report on Tuesday, April 1st. They set an “equal weight” rating and a $36.00 price target on the stock. Robert W. Baird cut their price target on Astrana Health from $86.00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Finally, Stifel Nicolaus cut their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th.

Institutional Trading of Astrana Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of Astrana Health in the fourth quarter worth about $40,000. Quarry LP boosted its stake in shares of Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company’s stock valued at $57,000 after purchasing an additional 471 shares during the period. Covestor Ltd grew its holdings in Astrana Health by 777.6% during the 1st quarter. Covestor Ltd now owns 2,001 shares of the company’s stock valued at $62,000 after purchasing an additional 1,773 shares in the last quarter. KBC Group NV increased its stake in Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company’s stock worth $80,000 after buying an additional 1,316 shares during the period. Finally, US Bancorp DE increased its stake in Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock worth $151,000 after buying an additional 4,656 shares during the period. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Stock Performance

NASDAQ ASTH opened at $27.08 on Friday. The stock’s fifty day moving average is $30.70 and its two-hundred day moving average is $34.90. The firm has a market capitalization of $1.52 billion, a P/E ratio of 20.83, a price-to-earnings-growth ratio of 1.37 and a beta of 1.00. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health has a fifty-two week low of $23.12 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.09). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $620.39 million during the quarter, compared to analysts’ expectations of $628.11 million. During the same quarter in the prior year, the firm earned $0.31 EPS. Astrana Health’s revenue for the quarter was up 53.4% compared to the same quarter last year. On average, research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.